A Phase 2 trial to test the use of nasal spray foralumab for the treatment of ALS has been accepted into the Healey ALS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback